Advancing Precision Medicine in Diffuse Large B Cell Lymphoma: Insights from the GUIDANCE-01 Trial
In September 2023, a study led by Professor Weili Zhao from Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, was published in the prestigious international academic journal ——Cancer Cell (IF=38.585). The…